Daniel K Spiegelman's Net Worth
$38.8 Million
Estimate Recalculated Apr 29, 2024 04:14PM EST
Who is Daniel K Spiegelman?
Daniel K Spiegelman has an estimated net worth of $38.8 Million. This is based on reported shares across multiple companies, which include Cascadian Therapeutics, Inc., Relypsa Inc, BIOMARIN PHARMACEUTICAL INC, OMEROS CORP, MYRIAD GENETICS INC, Cyclacel Pharmaceuticals, Inc., SPRUCE BIOSCIENCES, INC., Jiya Acquisition Corp., AFFYMAX INC, Anthera Pharmaceuticals Inc, and CV THERAPEUTICS INC.
SEC CIK
Daniel K Spiegelman's CIK is 0001238403
Past Insider Trading and Trends
2013 was Daniel K Spiegelman's most active year for acquiring shares with 18 total transactions. Daniel K Spiegelman's most active month to acquire stocks was the month of May. 2016 was Daniel K Spiegelman's most active year for disposing of shares, totalling 19 transactions. Daniel K Spiegelman's most active month to dispose stocks was the month of February. 2015 saw Daniel K Spiegelman paying a total of $4,023,129.30 for 196,048 shares, this is the most they've acquired in one year. In 2015 Daniel K Spiegelman cashed out on 208,287 shares for a total of $14,479,760.44, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Cascadian Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -21.01K |
—
|
—
|
0
|
Mar 9
| |||
Form 4
| +9.26% | 1.78K |
$3.94 | -$2,340.36 | 21.01K |
Sep 24
| |||
Form 4
| +54.64% | 6.79K |
$3.78 | -$8,561.70 | 19.23K |
Jun 24
| |||
Form 4
| +14.89% | 1.61K |
$3.34 | -$1,793.58 | 12.43K |
Jun 9 - Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 24
| |||
Form 4
| +29.60% | 12.03K |
$3.88 | -$15,562.68 | 52.67K |
Jun 12 - Jun 13
| |||
Form 4/A
| +96.88% | 20K |
$1.61 | $32,127.00 | 40.64K |
Mar 25 - Mar 26
| |||
Form 4
| +96.88% | 20K |
$1.61 | $32,127.00 | 40.64K |
Mar 25 - Mar 26
| |||
Form 4
| -43.94% | -16.18K |
$1.91 | -$30,907.41 | 20.64K |
Feb 20 - Jul 10
| |||
Form 4
| -5.26% | -2.04K |
$3.06 | -$6,254.64 | 36.83K |
Jun 6 - Jun 7
| |||
Form 4
| +59.59% | 14.51K |
$3.65 | -$17,658.70 | 38.87K |
Mar 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
| -4.45% | -1.14K |
$1.86 | -$2,111.10 | 24.36K |
Jun 9
| |||
Form 4
| +47.20% | 8.17K |
$3.67 | $29,998.58 | 25.49K |
Jun 7
| |||
Form 4
| -10.45% | -2.02K |
$3.51 | -$7,093.71 | 17.32K |
Jun 3
| |||
Form 4
| -7.40% | -1.55K |
$6.86 | -$10,605.56 | 19.34K |
Dec 4
| |||
Form 4
| +46.35% | 6.61K |
—
|
—
| 20.89K |
Jun 9 - Jun 12
| |||
Form 4
| +130.74% | 8.09K |
—
|
—
| 14.27K |
Jun 3
| |||
Form 4
|
∞
| 6.18K |
—
|
—
| 6.18K |
Dec 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Relypsa Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.49K |
$32.00 | -$111,584.00 |
0
|
Sep 1
| |||
Form 4
| +181.89% | 2.25K |
—
|
—
| 3.49K |
Jun 21
| |||
Form 4
| -45.02% | -1.01K |
$19.31 | -$19,561.64 | 1.24K |
Jun 7
| |||
Form 4
|
∞
| 2.25K |
—
|
—
| 2.25K |
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIOMARIN PHARMACEUTICAL INC (BMRN) Snapshot price: $90.1
EVP, Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.37% | 176 |
$68.78 | $12,105.63 | 47.69K |
Apr 30
| |||
Form 4
| -22.09% | -13.47K |
$89.00 | -$1,199,097.00 | 47.51K |
Scheduled
|
Apr 1
| ||
Form 4
| -0.16% | -100.00 |
$90.00 | -$9,000.00 | 60.98K |
Scheduled
|
Mar 27
| ||
Form 4
| -5.56% | -3.60K |
$88.05 | -$316,803.90 | 61.08K |
Mar 22
| |||
Form 4
| +3.43% | 2.14K |
$94.53 | -$683,168.31 | 64.68K |
Mar 15
| |||
Form 4
| +22.04% | 11.29K |
$94.76 | -$86,421.12 | 62.54K |
Mar 1
| |||
Form 4
| +0.34% | 175 |
$68.78 | $12,036.85 | 51.24K |
Oct 31
| |||
Form 4
| -16.37% | -10.00K |
$99.00 | -$990,004.72 | 51.07K |
Scheduled
|
Jun 22
| ||
Form 4
| -2.47% | -1.54K |
$80.43 | -$146,045.18 | 61.07K |
Apr 30 - Jun 4
| |||
Form 4/A
| -4.66% | -3.60K |
$81.36 | -$292,733.28 | 73.59K |
Mar 22
| |||
Form 4/A
| +21.90% | 12.62K |
—
|
—
| 70.22K |
Feb 26
| |||
Form 4
| -15.03% | -11.06K |
$82.15 | -$908,496.85 | 62.54K |
Scheduled
|
Apr 23
| ||
Form 4
| -4.64% | -3.58K |
$81.36 | -$291,512.88 | 73.6K |
Mar 22
| |||
Form 4
| +12.65% | 8.66K |
$83.57 | -$318,819.55 | 77.19K |
Mar 15
| |||
Form 4
| -2.29% | -1.61K |
$79.86 | -$128,494.74 | 68.52K |
Mar 2
| |||
Form 4
| +21.75% | 12.53K |
—
|
—
| 70.13K |
Feb 26
| |||
Form 4/A
|
—
|
0
|
$98.91 | -$2,119,310.82 | 75.58K |
Scheduled
|
May 27
| ||
Form 4
| -7.17% | -1.80K |
$90.72 | -$163,386.72 | 23.3K |
Jun 2
| |||
Form 4
| -5.88% | -1.57K |
$80.90 | -$146,665.88 | 25.1K |
Apr 28 - May 15
| |||
Form 4
| +84.31% | 12.2K |
—
|
—
| 26.67K |
Mar 22
| |||
Form 4
| -30.30% | -6.29K |
$92.33 | -$580,750.94 | 14.47K |
Scheduled
|
Mar 15 - Mar 16
| ||
Form 4
| -9.99% | -2.30K |
$93.32 | -$214,915.96 | 20.76K |
Scheduled
|
Mar 6
| ||
Form 4
| -9.01% | -2.28K |
$93.95 | -$214,487.85 | 23.06K |
Mar 3
| |||
Form 4
| -16.48% | -5.00K |
$78.58 | -$1,399,500.00 | 25.35K |
Scheduled
|
Feb 28 - Mar 1
| ||
Form 4
| +67.66% | 12.25K |
—
|
—
| 30.35K |
Feb 24
| |||
Form 4
| -21.65% | -5.00K |
$90.00 | -$450,000.00 | 18.1K |
Scheduled
|
Jan 9
| ||
Form 4
| -46.21% | -19.84K |
$79.53 | -$1,801,529.05 | 23.1K |
Oct 31 - Nov 9
| |||
Form 4
| -8.52% | -4.00K |
$99.33 | -$397,320.00 | 42.94K |
Scheduled
|
Aug 1
| ||
Form 4
| -3.39% | -1.65K |
$89.14 | -$146,991.86 | 46.94K |
Scheduled
|
Jun 6
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
| -3.57% | -1.80K |
$90.00 | -$162,090.00 | 48.59K |
Jun 3
| |||
Form 4
| -7.26% | -3.94K |
$64.47 | -$1,213,167.99 | 50.39K |
Scheduled
|
May 31
| ||
Form 4
| -7.34% | -4.30K |
$89.09 | -$383,532.45 | 54.34K |
May 27
| |||
Form 4
| -6.04% | -3.77K |
$87.07 | -$328,184.17 | 58.64K |
Scheduled
|
May 23
| ||
Form 4
| -2.38% | -1.52K |
$66.99 | -$132,071.29 | 62.41K |
Apr 29 - May 13
| |||
Form 4
| +35.18% | 16.64K |
—
|
—
| 63.93K |
Mar 15
| |||
Form 4
| -4.82% | -2.40K |
$89.57 | -$214,520.15 | 47.29K |
Mar 3
| |||
Form 4
| -50.84% | -51.39K |
$82.25 | -$4,226,852.24 | 49.69K |
Scheduled
|
Feb 29 - Mar 2
| ||
Form 4
| +255.35% | 72.63K |
—
|
—
| 101.08K |
Feb 24
| |||
Form 4
|
—
|
0
|
$71.68 | -$1,304,718.00 | 28.23K |
Scheduled
|
Nov 16
| ||
Form 4
| -10.89% | -3.45K |
$121.34 | -$418,617.53 | 28.23K |
Scheduled
|
Jun 4 - Jun 5
| ||
Form 4
| -23.68% | -9.83K |
$125.10 | -$1,229,455.07 | 31.68K |
Scheduled
|
May 29 - Jun 1
| ||
Form 4
| -45.09% | -34.08K |
$130.00 | -$4,430,140.00 | 41.51K |
Scheduled
|
May 18
| ||
Form 4
| +0.54% | 425 |
$122.27 | $49,988.96 | 75.58K |
Scheduled
|
Apr 30 - May 18
| ||
Form 4
| +15.27% | 10.5K |
—
|
—
| 79.28K |
Mar 3
| |||
Form 4
|
—
|
0
|
$73.03 | -$1,053,070.00 | 68.68K |
Mar 2
| |||
Form 4
| +0.08% | 57 |
$67.63 | $3,441.41 | 68.73K |
Mar 18 - Sep 3
| |||
Form 4
|
—
|
0
|
$54.45 | -$492,353.60 | 68.68K |
Sep 2
| |||
Form 4
| -3.14% | -2.23K |
$61.76 | -$137,651.90 | 68.68K |
Aug 1
| |||
Form 4
| -3.05% | -2.23K |
$64.00 | -$142,656.00 | 70.91K |
Jul 2
| |||
Form 4
| +23.26% | 13.8K |
—
|
—
| 73.13K |
Jun 4
| |||
Form 4
| -6.01% | -3.79K |
$57.50 | -$218,040.00 | 59.33K |
May 29
| |||
Form 4
| -1.78% | -1.15K |
$53.47 | -$66,630.46 | 63.13K |
Apr 30 - May 15
| |||
Form 4
|
—
|
0
|
$59.69 | -$330,050.40 | 64.27K |
Scheduled
|
Mar 3
| ||
Form 4
| +69.04% | 26.25K |
—
|
—
| 64.27K |
Feb 14
| |||
Form 4
|
—
|
0
|
$54.60 | -$279,732.60 | 37.95K |
Scheduled
|
Dec 2
| ||
Form 4
|
—
|
0
|
$54.03 | -$269,460.00 | 37.95K |
Scheduled
|
Sep 4
| ||
Form 4
| -9.68% | -4.07K |
$59.78 | -$243,063.04 | 37.95K |
Scheduled
|
Jul 1
| ||
Form 4
| -9.06% | -4.18K |
$64.46 | -$269,700.64 | 42.02K |
May 29
| |||
Form 4
| +40.00% | 13.2K |
—
|
—
| 46.2K |
May 15
| |||
Form 4
|
—
|
0
|
$51.74 | -$710,217.20 | 33K |
May 1
| |||
Form 4
|
∞
| 33K |
—
|
—
| 33K |
May 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OMEROS CORP (OMER) Snapshot price: $3.2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MYRIAD GENETICS INC (MYGN) Snapshot price: $22.2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +19.17% | 6.51K |
$23.01 | -$198,760.38 | 40.49K |
Jun 1 - Jun 2
| |||
Form 4
| -15.90% | -6.42K |
$19.25 | -$123,672.92 | 33.98K |
Scheduled
|
Jun 6
| ||
Form 4
| +74.69% | 17.27K |
—
|
—
| 40.4K |
Jun 2
| |||
Form 4
| -11.95% | -3.14K |
$30.52 | -$95,794.75 | 23.13K |
Scheduled
|
Jun 17
| ||
Form 4
| +95.74% | 12.85K |
—
|
—
| 26.27K |
Jun 3
| |||
Form 4
| -34.73% | -7.14K |
$28.99 | -$207,023.01 | 13.42K |
Scheduled
|
May 28
| ||
Form 4
| -43.59% | -15.89K |
—
|
—
| 20.56K |
May 27
| |||
Form 4
| +77.27% | 15.89K |
—
|
—
| 36.45K |
Dec 4
| |||
Form 4
|
∞
| 20.56K |
—
|
—
| 20.56K |
May 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||